Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Empagliflozin and Linagliptin on Renal Function and Diabetes Control
TCTR20251220005Phase 3Recruiting
- Sponsor
- Pak Emirates Military Hospital
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of empagliflozin, linagliptin in type 2 diabetes mellitus (T2DM), sponsored by Pak Emirates Military Hospital. Started Apr 2025; status: recruiting.
02
Drugs
empagliflozinlinagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on TCTR20251220005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251220005.